PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Drugs10.1007/s40265-019-01170-5201979131367-1374Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced DyskinesiaThomas Müller, Jan-Dominique Möhrhttp://link.springer.com/content/pdf/10.1007/s40265-019-01170-5.pdf, http://link.springer.com/article/10.1007/s40265-019-01170-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40265-019-01170-5.pdf
Journal of Movement Disorders10.14802/jmd.190292019123161-165Recent Advances in the Development of Experimental Therapeutics for Levodopa-Induced DyskinesiaMichael L. Martini, Sean N. Neifert, J Mocco, Fedor Panov, Winona Tse, Ruth H. Walker, Jian Jin, Fiona Guptahttp://e-jmd.org/upload/jmd-19029.pdf, http://e-jmd.org/journal/view.php?doi=10.14802/jmd.19029, http://e-jmd.org/upload/jmd-19029.pdf
Drugs10.1007/s40265-016-0566-32016767759-777Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced DyskinesiaDhanya Vijayakumar, Joseph Jankovichttp://link.springer.com/content/pdf/10.1007/s40265-016-0566-3.pdf, http://link.springer.com/article/10.1007/s40265-016-0566-3/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40265-016-0566-3
10.1007/978-1-4471-6503-32014Levodopa-Induced Dyskinesia in Parkinson's Diseasehttp://link.springer.com/content/pdf/10.1007/978-1-4471-6503-3.pdf, http://link.springer.com/content/pdf/10.1007/978-1-4471-6503-3
Reactions Weekly10.1007/s40278-016-20349-y201616141119-119Levodopahttp://link.springer.com/content/pdf/10.1007/s40278-016-20349-y.pdf, http://link.springer.com/article/10.1007/s40278-016-20349-y/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-20349-y
Reactions Weekly10.1007/s40278-019-71410-0201917791146-146Levodopa/carbidopahttp://link.springer.com/content/pdf/10.1007/s40278-019-71410-0.pdf, http://link.springer.com/article/10.1007/s40278-019-71410-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-019-71410-0.pdf
Movement Disorders10.1002/mds.87007051019927S19-9Levodopa-induced dyskinesiaAgid Yveshttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.870070510, https://onlinelibrary.wiley.com/doi/full/10.1002/mds.870070510
Clinical Pharmacology & Therapeutics10.1002/cpt19782321951978232195-198Cyproheptadine in levodopa-induced dyskinesia in parkinsonismPaul S. Papavasiliou, George C. Cotzias, Fletcher H. McDowell, Victoria L. F. Rosal, Paul J. Sheehanhttp://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1978232195, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt1978232195
Therapeutics and Clinical Risk Management10.2147/tcrm.s1444812018Volume 14665-673Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's diseaseVibhash Sharma, Kelly Lyons, Rajesh Pahwahttps://www.dovepress.com/getfile.php?fileID=41489, https://www.dovepress.com/getfile.php?fileID=41489
Movement Disorders10.1002/mds.23244201025111527-1529Direct and indirect pathways in levodopa-induced dyskinesia: A more complex matter than a network imbalanceVeronica Ghiglieri, Barbara Picconi, Paolo Calabresihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.23244, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fmds.23244, http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23244/fullpdf